Synthesis, biodistribution and radiation dosimetry of a novel mGluR5 radioligand: [18F]AZD9272

The metabotropic glutamate receptor subtype mGluR5 has been proposed as a potential drug target for CNS disorders such as anxiety, depression, Parkinson’s disease and epilepsy. The AstraZeneca comp...